HALOZYME THERAPEUTICS, INC. (HALO) Revenue 2016–2025
HALOZYME THERAPEUTICS, INC. (HALO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.4BFY2025 · since FY2016: $146.7M → $1.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.4B | +37.6% |
| FY2024 | $1.0B | +22.4% |
| FY2023 | $829.3M | +25.6% |
| FY2022 | $660.1M | +48.9% |
| FY2021 | $443.3M | +65.7% |
| FY2020 | $267.6M | +36.5% |
| FY2019 | $196.0M | +29.1% |
| FY2018 | $151.9M | -52.0% |
| FY2017 | $316.6M | +115.8% |
| FY2016 | $146.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice